Deals & Cases
- Kellerhals Carrard advises on the sale of a majority stake in Hipp Technology Group
March 24, 2026 - Kellerhals Carrard berät Eigentümer der Tretor AG bei Transaktion mit Pictet Alternative Advisors
March 11, 2026 - Deal Ticker: Kellerhals Carrard advised on the sale of Lakera
November 6, 2025 - Deal Ticker: Kellerhals Carrard advised Sofinnova Partners and Earlybird Venture Capital on financing round with HAYA Therapeutics
May 15, 2025 - Deal Ticker: Kellerhals Carrard Advised MoonLake Immunotherapeutics on Debt Financing with Hercules Capital, Inc.
April 4, 2025 - Kellerhals Carrard Advises on the Sale of Baccinex S.A. to Adragos Pharma
December 3, 2024 - Deal Ticker: Kellerhals Carrard Advised on Acquisition of Majority Stake in Walter Meier (Fertigungslösungen) AG
May 27, 2024 - Deal Ticker: Novartis hands over the Life-Science-Park Rhine Valley to GETEC Switzerland.
August 23, 2023 - Deal Ticker: Kellerhals Carrard acted as lead counsel in connection with Biognosys’ strategic partnership with Bruker Corporation
January 6, 2023 - Deal Ticker: Kellerhals Carrard advised BVF on the purchase agreement with NLS Pharmaceutics.
December 19, 2022 - MoonLake Immunotherapeutics AG Announces Closing of Business Combination with Helix Acquisition Corp.April 6, 2022
- Deal-Ticker: Swiss entrepreneurial group led by Kontivia acquires majority stake in Katadyn Group
October 13, 2021